RK

Ratnaningrum Karuna

R&d & Project Management Lead at Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)

Ratnaningrum (Ratna) Karuna has extensive experience in the pharmaceutical and biomedical research industries. Ratnaningrum (Ratna) is currently serving as the R&D & Project Management Lead at Prestige BioPharma Ltd, where they lead the R&D teams in Singapore and oversees various aspects of drug development, including cell line development, preclinical studies, clinical bioanalysis, and regulatory submissions.

Prior to their current role, Ratna worked at A*STAR - Agency for Science, Technology and Research as the Group Leader of the Experimental Drug Development Centre (EDDC) from 2017 to 2021.

Ratnaningrum (Ratna) also held positions at Novartis Institutes for BioMedical Research (NIBR), where they served as the DMPK Lead & Laboratory Head at the Novartis Institute for Tropical Diseases (NITD) from 2012 to 2017. In this role, they managed a bioanalysis lab and acted as a Drug Development Project Team Representative.

Before that, Ratna worked at NIBR as a Research Investigator in the Analytical Science and Imaging Division from 2010 to 2011, where they developed sensitive LC-MS methods for biomarker evaluation.

Ratna's earlier career includes positions as a Research Assistant in the Division of Pharmacology and the Division of Analytical BioSciences at Leiden University from 2003 to 2005. Ratnaningrum (Ratna)'sresponsibilities included setting up and maintaining LC-MS instruments, knowledge transfer to other technicians, small molecule method development, and screening human plasma for electroactive metabolites.

Additionally, they worked as a Freelance Journalist at MARE, Leids Universitair Weekblad (English Page) in 2004.

Overall, Ratnaningrum (Ratna) Karuna possesses a strong background in drug development, project management, bioanalytics, and analytical science.

Ratna Karuna completed their education in the following sequence:

- From 1995 to 2000, they obtained a Bachelor of Science degree in Pharmaceutical Science from Universitas Airlangga.

- Following that, from 1999 to 2000, they obtained a Pharmacist degree (Apt.) from the same university.

- Later, from 2001 to 2004, they pursued a Master of Science degree in Pharmaceutical Science from Leiden University.

- Lastly, from 2006 to 2010, they completed their Doctor of Science (Dr. Sc.) degree in Analytical Chemistry from ETH Zürich.

Links

Previous companies

Novartis logo
Leiden University logo

Timeline

  • R&d & Project Management Lead

    September, 2021 - present